Siyu Li

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang et al. · The Lancet Oncology · 2020 · 457 citations · Full text

Single-arm Trial, Medicine, Pathology +5

General features to enhance enzymatic activity of poly(ethylene terephthalate) hydrolysis

Chun‐Chi Chen, Xu Han, Xian Li et al. · Nature Catalysis · 2021 · 219 citations

Engineering, Biochemistry, Natural Sciences +8

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

Danny Rischin, Michael R. Migden, Annette M. Lim et al. · Journal for ImmunoTherapy of Cancer · 2020 · 169 citations · Full text

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

Cancer Management, Median Time, Dermatology +16